Business Update2 Sept 2025, 05:41 pm
AstraZeneca Pharma India Ltd Surrenders Manufacturing License to Drugs Controller and Licensing Authority
AI Summary
AstraZeneca Pharma India Limited has surrendered its manufacturing license, which was valid up to December 2027, to the Drugs Controller and Licensing Authority for cancellation. This decision comes after the company's earlier intimation to stock exchanges on June 21, 2024, regarding the exit from their manufacturing site. The company secretary, Manasa Rama A Rama, has signed the intimation digitally.
Key Highlights
- AstraZeneca Pharma India Ltd has surrendered its manufacturing license for cancellation.
- The manufacturing license was valid up to December 2027.
- The decision comes after the company's earlier intimation to stock exchanges regarding the exit from their manufacturing site.
- The intimation was signed digitally by the company secretary, Manasa Rama A Rama.